Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin

Simple device can reduce death risk for Americans with diabetes

For more than 38 million Americans, wearing a simple continuous glucose monitoring device may lower their risk of dying.

Continuous glucose monitors show strong survival benefits for type 2 diabetes patients

People with type 2 diabetes (T2D) on basal insulin, starting continuous glucose monitoring (CGM) had a 44% lower risk of dying from any cause after one year compared with those who did not use CGM, with the risk being 35% lower after two years, according to an analysis of patient data being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2).

Continuous glucose monitoring may lower mortality risk in diabetic patients on insulin

People with type 2 diabetes (T2D) who began using continuous glucose monitoring (CGM) while receiving basal insulin had a 44% lower risk of dying from any cause after one year than those who did not use CGM, according to an analysis of patient data being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct. 2. After two years, their risk was 35% lower.

Type 2 diabetes: Continuous glucose monitoring linked to lower risk of death, heart problems

Continuous glucose monitoring was linked to lower risks of death, cardiovascular events and heart failure hospitalisation in type 2 diabetes patients.